| Old Articles: <Older 37451-37460 Newer> |
|---|
 |
Chemistry World
July 24, 2009
Matt Wilkinson |
Pharma's shot in the arm? As swine flu cases continue to erupt around the globe, the latest financial results from pharmaceutical companies Roche and GlaxoSmithKline reveal that sales of their antiviral drugs have soared.   |
The Motley Fool
July 24, 2009
Toby Shute |
Ensco's Halfway There The driller's deepwater buildout is going swimmingly. |
The Motley Fool
July 24, 2009
David Lee Smith |
3M Keeps Posting Profits With some companies disappointing, the Post-It maker turns in a solid quarter. |
The Motley Fool
July 24, 2009
Chris Hill |
3 Stocks on Our Radar McDonald's, Morgan Stanley, and Microsoft are discussed in the latest podcast. |
The Motley Fool
July 24, 2009
Christopher Barker |
The New Floor Under Nucor Consensus builds that the bottom is in for steel. |
The Motley Fool
July 24, 2009
Matt Koppenheffer |
This Investing Guru Says the Rally Is for Real After watching Bill Miller of Legg Mason's Value Trust mutual fund get trounced by the market over the past couple of years, should we trust his bullishness? |
The Motley Fool
July 24, 2009
Robert Steyer |
Gambling's Not-So-Great Expectations International Game Technology beat Wall Street's forecast for the March-June quarter, but is that proof of a turnaround? |
The Motley Fool
July 24, 2009
Rick Aristotle Munarriz |
This Week's 5 Dumbest Stock Moves Companies that are guilty of dumb strategies are Bankrate, Barnes & Noble, and Yahoo, along with Starbucks and Intel. |
The Motley Fool
July 24, 2009
Mike Pienciak |
Wipro's Not Whipped The company is holding up well, but the stock has room to fall. |
The Motley Fool
July 24, 2009
Christopher Barker |
Worth the Wait? Newmont and fellow miners anticipate production growth for the second half. |
| <Older 37451-37460 Newer> Return to current articles. |
